Candida glabrata Endophthalmitis Treated Successfully with Caspofungin | Zendy

Juan C. Sarria | Zendy; JeanClaude Bradley | Zendy; Riadh Habash | Zendy; Kelly Mitchell | Zendy; Robert C. Kimbrough | Zendy; A. M. Vidal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Candida glabrata Endophthalmitis Treated Successfully with Caspofungin

Author(s) -

Juan C. Sarria,

JeanClaude Bradley,

Riadh Habash,

Kelly Mitchell,

Robert C. Kimbrough,

A. M. Vidal

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/427753

Subject(s) - caspofungin , medicine , fluconazole , candida glabrata , endophthalmitis , amphotericin b , vitrectomy , mycosis , surgery , antifungal , microbiology and biotechnology , visual acuity , dermatology , biology

A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research